← All Enpro INC filings

Enpro INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
NPO
Enpro INC
DEF: Enpro Inc. 2026 Proxy Details Governance, Pay, Growth
Enpro Inc.'s 2026 proxy statement outlines director elections, executive compensation, and strategic initiatives, including strong 2025 financial performance and sustainability progress.
NYSE
NPO
Enpro INC
DEFA14A: Enpro Inc. Updates Proxy Material with Director's New Role at NewAmsterdam Pharma
Enpro Inc. has updated its proxy statement to reflect Adele M. Gulfo's election to the board of directors of NewAmsterdam Pharma Company N.V.
NYSE
NPO
Enpro INC
DEFA14A: Enpro Inc. Updates Proxy Material with Director's New Board Appointment
Enpro Inc. has updated its proxy statement to reflect director Ronald C. Keating's election to the board of Hayward Holdings, Inc.
NYSE
NPO
Enpro INC
DEF: Enpro Inc. Announces 2025 Annual Meeting of Shareholders, Outlines Key Proposals
Enpro Inc. details proposals for its 2025 Annual Meeting, including director elections, executive compensation approval, equity plan amendment, and auditor ratification.
NYSE
NPO
Enpro INC
DEF 14A: Enpro Inc. Outlines Director Nominees, Executive Compensation, and Corporate Governance in 2024 Proxy Statement
Enpro Inc.'s 2024 proxy statement details the election of directors, executive compensation, and corporate governance practices to be voted on at the annual shareholder meeting.